Short answer
ASP Isotopes Inc. (ASPI) filed an 8-K current report with the SEC on July 28, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Reg FD item covers a press release containing forward-looking statements.
ASP Isotopes Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Reg FD item covers a press release containing forward-looking statements
- Safe-harbor language limits liability for projections under the Private Securities Litigation Reform Act
- Investors should distinguish disclosed expectations from historical operating results
Item EX-99.1 · Exhibit EX-99.1
- Capital Markets Day scheduled for September 8, 2026, offering investors a strategic and commercial update
- Management focus: nuclear medicine, electronic gases, and nuclear fuels market opportunities
- Public webcast and formal Q&A run from 10:00 a.m. to 12:30 p.m. ET
- Event may provide updated visibility into commercialization plans for ASP and QE enrichment technologies
- Proposed ENDRA merger remains subject to SEC filings, stockholder approval, and closing conditions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ASP Isotopes Inc. 8-K filings
Get the next ASPI 8-K as it lands
Follow ASPI for push alerts, or ask the research agent what this filing means.